Introduction
NK cells, T cells and B cells comprise the three subsets of lymphocytes in the mammalian immune system (1) . NK cells are large, granular lymphocytes capable of killing tumors and virally-infected cells without prior immunization (reviewed in 2), and may play an important role in the innate, as well as adaptive immune systems (3) . NK cells are important in bone marrow transplantation (BMT) since they are relatively radioresistant (4) and are involved in the rejection of allogeneic bone marrow cells, as well as the rejection of parental bone marrow grafts in F 1 recipients, a phenomenon known as hybrid resistance (5, 6) .
Recent studies have shown that NK cells can distinguish allogeneic cells from 'self' and that the presence of 'self' class I MHC molecules can protect target cells from NK cellmediated lysis (7) (8) (9) (10) . Several models have been proposed
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Correspondence to: M. Sykes Received 15 December 1998, accepted 8 September 1998 to explain the mechanisms by which self-class I MHC inhibits lysis by NK cells. The 'missing self' hypothesis (11) states that NK cell targets become susceptible to NK cell killing due to the lack of expression of self MHC molecules. Tumor cell lines that down-modulate MHC molecules are sensitive to NK cell killing, and studies using β2-microglobulin (β 2 m)-deficient (β 2 m -/-) mice have demonstrated that β 2 m -/-target cells are killed more efficiently than β 2 m ϩ/ϩ targets by NK cells from normal mice (12, 13) . Resistance to engraftment of parental marrow in F 1 recipients may also be explained by these observations, since only one of the F 1 's MHC molecules at any particular locus is expressed by the parental bone marrow. Thus, subsets of F 1 NK cells that rely on recognition of the other MHC haplotype for inhibition of killing would be capable of killing parental cells that lack this MHC haplotype.
This recognition of self MHC molecules is mediated by Ly-49 receptors on murine NK cells. This family of receptors is expressed in a clonally distributed fashion on subsets of NK cells whose killing is inhibited by particular MHC molecules (reviewed in 14, 15) . Individual members of the Ly-49 family recognize specific MHC class I molecules and an inhibitory signal is transmitted when Ly-49 receptors bind to their respective MHC class I ligands. The inhibitory signal is dependent on an immune receptor tyrosine-based inhibitory motif sequence found in the cytoplasmic tail of certain Ly-49 molecules, which is required for the binding of a tyrosine phosphatase involved in transmitting the inhibitory signal (16) . To date, several Ly-49 receptors have been identified and cloned in the mouse (Ly-49A-I), and strain-specific allelic forms have been described (17) (18) (19) (20) (21) . Since Ly-49 receptors recognize specific MHC class I ligands, it is likely that these receptors are important in the development of self-tolerance among NK cells.
The 'receptor calibration model' (22) states that in order for NK cells to be tolerant to self MHC antigens, they must express at least one Ly-49 receptor that is specific for self MHC. According to this model, the strength of the inhibitory signal generated by an NK cell/potential target cell interaction may depend on the affinities of the Ly-49 receptors for their respective ligands, the number of Ly-49 receptors on the cell surface and the number of MHC ligands present on the target cell. The combination of these three factors results in sufficient avidity such that an overall, minimal inhibitory threshold is achieved when NK cells encounter self targets that express 'normal' levels of class I. If the system is perturbed (as can occur in association with viral infection or malignant transformation) and the level of MHC class I is reduced, the inhibitory signal is reduced, allowing NK cell activation and killing to proceed.
Since different Ly-49 molecules have varying affinities for particular class I alleles, NK cells must 'learn' what is the appropriate amount of expression of particular Ly-49 molecules in order for this functional state to be attained. The mechanisms which regulate the expression of certain Ly-49 receptors currently are poorly understood. Previous studies in our laboratory, in which NK cells of mixed and fully allogeneic bone marrow chimeras were examined, showed that both hematopoietic cells and radioresistant host elements influence the expression of a Ly-49 molecule that recognizes D d (23) . We have now used the mixed allogeneic bone marrow chimera model (24) to further address this question, by examining the expression of various Ly-49 receptors, whose MHC ligands are known, on NK cells developing in the presence of allogeneic MHC antigens. Mixed allogeneic bone marrow chimeras provide an excellent model in which to study NK cell tolerance, as NK cells of both host and donor origin develop in the presence of both donor and host hematopoietic cells. Since chimerism is stable long term in such animals, we hypothesized that NK cells of both types would be tolerant to the other's MHC antigens. We hypothesized that the requirement that individual NK cells in mixed chimeras be tolerant of both donor and host cells would result in alterations in the expression of various Ly-49 receptors. Changes in the levels of expression of Ly-49 receptors were indeed observed in response to BMT, suggesting that alterations of Ly-49 receptor expression allow NK cells to recognize both host and donor antigens as 'self'. However, in vitro NK cell assays did not show tolerance of donor and host NK cells towards host and donor antigens respectively. The implications of these apparently contradictory results are discussed.
Methods

Mice
C57BL/6 (H-2 b ) (B6) and BALB/c (H-2 d ) mice, 6-10 weeks old, were purchased from the Frederick Cancer Research Facility (Frederick, MD). C57BL/6-β 2 m -/-mice were purchased from Jackson Laboratories (Bar Harbor, ME). Animals were housed in sterile microisolator cages, and fed autoclaved feed and autoclaved, acidified drinking water.
Preparation of mixed chimeras
Mixed chimeras were prepared using a previously described non-myeloablative conditioning regimen followed by BMT (24) . Briefly, B6 recipients were treated with depleting doses of anti-CD4 (GK1.5) and anti-CD8 (2.43) mAb on day -5 before BMT, and 7 Gy thymic irradiation and 3 Gy whole body irradiation plus 2ϫ10 7 donor BALB/c bone marrow cells were administered on day 0. Animals receiving such treatment demonstrate long-term mixed chimerism in all hematopoietic lineages and specific T cell tolerance to donor antigens (24, 25) . B6 and BALB/c mice receiving the conditioning regimen but no BMT were also prepared as non-transplanted, conditioned controls.
Flow cytometry (FCM)
Preparation of tissues. Peripheral blood was collected into heparinized tubes and white blood cells were prepared by hypotonic lysis of red blood cells. On the day of sacrifice, spleens were harvested and gently crushed in ACK Lysing Buffer (Biowhittaker, Walkersville, MD) to lyse red cells, and were resuspended in RPMI 1640 (Mediatech, Herndon, VA) containing 10% fetal bovine serum (Sigma, St Louis, MO), L-glutamine, penicillin/streptomycin, 2-mercaptoethanol and 0.01 M HEPES buffer. Bone marrow cells were harvested from the femurs and tibiae by flushing the bones with FACS media.
Antibodies. The following mAb were used: A1 (anti-Ly-49A)-FITC, RM4-4 (anti-CD4)-FITC, 53-5.8 (anti-CD8β)-FITC, mouse anti-rat IgG2a-FITC, mouse anti-rat IgG2b-FITC, 5E6 (anti-Ly-49C/I)-FITC and -phycoerythrin (PE), PK136 (anti-NK1.1)-PE, purified DX5 (rat IgM anti-mouse pan-NK cell marker), DX5-FITC, mouse anti-rat IgM-PE, rat IgG2a-PE, 34-2-12 (anti-D d )-biotin, KH95 (anti D b )-biotin, 1D3 (anti-CD19)-biotin and 2C11 (anti-CD3ε)-biotin (all purchased from PharMingen, San Diego, CA). MAC-1 (anti-CD11b)-FITC was purchased from Caltag (South San Francisco, CA). HOPC-FITC and HOPC-biotin, non-specific mouse IgG2a mAb, were used as negative staining controls. Purified rat IgG2a (PharMingen) was used to block free sites on mouse anti-rat IgG2a-FITC when necessary. 5E6 ascites was a gift from Dr Henry Winn (Massachusetts General Hospital, Boston, MA). The YE1/48 (rat IgG2b anti-mouse Ly-49A)-producing hybridoma was kindly provided by Dr John Ortaldo (National Cancer Institute, Frederick, MD). mAb 5E6 and YE1/48 were purified from ascites or bioreactor supernatants, respectively, and were FITC conjugated using the Quick Tag kit (Boehringer Mannheim, Indianapolis, IN). Biotinylated 4LO3311 mAb was kindly provided by Dr Suzanne Lemieux (Universite du Quebec, Laval, Quebec, Canada). The 4D11-producing hybridoma cell line was obtained from the ATCC (Rockville, MD. mAb 2.4G2 (rat anti-mouse FcγR) was added to all tubes except those containing mouse anti-rat IgG2b-FITC as a secondary reagent. Biotinylated mAb were developed with either phycoerthryin-streptavidin (PEA) or CyChrome-streptavidin (CCA) (PharMingen), in two-color or three-color staining protocols respectively.
For mAb staining, cells were resuspended in FACS media consisting of 1ϫHBSS, 0.1% sodium azide and 0.1% BSA. For multiple-color staining, cells were incubated with mAb for 30 min at 4°C and washed once before the addition of the next mAb/fluorochrome. Cells were incubated with PEA and CCA for 10 min at 4°C, then washed and analyzed on a FACScan flow cytometer (Becton Dickinson). Cells not analyzed on the same day as staining were fixed with 2% paraformaldehyde in 1ϫPBS for 10 min, resuspended in 0.3 ml FACS media and stored in the dark at 4°C until analysis. For two-color stains, propidium iodide was used to exclude dead cells during analysis. For three-color staining, dead cells, red blood cells, macrophages and granulocytes were excluded on the basis of forward angle and 90°light scatter characteristics, and then specific cell populations were collected as described in Results. Between 1000 and 5000 gated events were collected for analysis. Data analysis was performed using either CellQuest (Becton Dickinson, San Jose, CA), WinList (Verity Software House, Topsham, ME) or Windows Multiple Document Interface for Flow Cytometry (WinMDI; Scripps Research Institute, La Jolla, CA) software.
To determine percentages of NK cells staining with particular mAb, background staining (non-specific control mAb or secondary mAb alone) was subtracted from the percentage of cells in the positive peak. To calculate the ratios of 5E6 ϩ 4D11 ϩ [double positive (DP)] cells to the total 5E6 ϩ or total 4D11 ϩ population, the following formula was used: (% DP - Autologous spleen cells or a 50:50 mixture of BALB/c and B6 spleen cells were irradiated with 3000 rad and used as feeder cells. Purified NK cells were cultured in 6-or 24-well-plates at a concentration of 2ϫ10 6 /ml with an equal number of feeder cells in 1000 U/ml IL-2 for 4 days in a 37°C incubator with 5-7% CO 2 . Culture media consisted of RPMI 1640 (Mediatech, Herndon, VA) containing 10% fetal bovine serum (Sigma), 0.09 mM non-essential amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin/100 µg streptomycin, 0.025 mM β-mercaptoethanol and 0.01M HEPES buffer. After culture, the activated NK cells were, on average, 85% DX5 ϩ CD3 -as determined by flow cytometry and no CD3 ϩ cells were present in the suspension. Activated NK cells were co-cultured with 51 Cr-labeled 48-h concanavalin A lymphoblasts from host, donor or B6-β 2 m -/-mice at specific E:T ratios in 96-well V-bottom plates (Costar, Cambridge, MA). Between 1000 and 5000 targets were used per well. After 4 h of co-culture, culture supernatants were harvested using the Titertek supernatant collection system (Skatron, Sterling, VA) and 51 Cr release was determined with an automated γ-counter. Percent specific lysis (PSL) was calculated with the formula: PSL ϭ [(experimental release -spontaneous release)/(maximum release -spontaneous release)]ϫ100%. Differences in PSL values between different targets were analyzed with a two-tailed t-test to compare specific lysis values, estimating the standard error of the specific lysis values using propagation of error and Satterthwaite's formula for degrees of freedom (27) . Differences in killing of a single target type by different effectors were analyzed using a two-tailed t-test to compare mean c.p.m. (Microsoft Excel software). Differences were considered significant if P Ͻ 0.05.
Results
Analysis of host and donor-type NK cells in mixed chimeras
Since Ly-49 receptors bind to MHC class I ligands and are thought to be important in distinguishing self from non-self, we hypothesized that Ly-49 receptors might be involved in the development of NK cell tolerance in mixed allogeneic chimeras. Using three-color FCM, we examined the expression of Ly-49A, Ly-49C and Ly-49G2 on freshly isolated splenic NK cells developing in BALB/c → B6 mixed chimeras. Host (B6) NK cells were examined by gating on NK1.1 ϩ CD3 -or DX5 ϩ CD3 -D d-cells during acquisition. Donor (BALB/c) NK cells were examined by gating on DX5 ϩ CD3 -D b-spleen cells. The mAb DX5 (28) is a newly described mAb which is specific for a 'pan-NK cell marker', as it stains a population of CD19 -CD3 -spleen cells in all mouse strains tested. In B6 mice, DX5 is expressed on Ͼ95% of NK1.1 ϩ CD19 -CD3 -spleen cells and on~6% of NK1.1 -CD19 -CD3 -spleen cells, and Ly-49A, Ly-49C and Ly-49G2 are also expressed on DX5 ϩ cells (28 and data not shown). Bone marrow engraftment and the presence of chimerism were confirmed in each individual animal by FCM analysis of the bone marrow and spleen for the presence of donor MHC class I antigens at the time of sacrifice (data not shown). 
Altered expression of Ly-49A on NK cells in mixed chimeras
Ly-49A is recognized by mAb A1 and YE1/48 (29, 30) , and transmits inhibitory signals upon recognition of D d and D k (31) . Consistent with our previous findings (23), Ly-49A expression, detected by the mAb A1, was down-regulated on host (B6) NK cells in BALB/c → B6 mixed chimeras compared to that of similarly-treated, non-transplanted B6 control animals ( Fig. 1A and C; summarized in Table 1 ). A1 does not stain the BALB/c allele of Ly-49A (32), so this mAb did not permit detection of Ly-49A on donor (BALB/c) NK cells or BALB/c controls ( Fig. 1B and D) . The reduction in Ly-49A expression on host (B6) NK cells in mixed chimeras was due to downregulation or loss of an epitope recognized by A1 and not to deletion of the Ly-49A ϩ NK cells, as staining with another Ly-49A-specific mAb, YE1/48 (33), revealed a positive peak. The level of YE1/48 staining was reduced in intensity on host (B6) NK cells of mixed chimeras compared to those of nontransplanted B6 controls (Figs 1E and G). The differences between the median fluorescence intensity (MFI) of the YE1/ 48 ϩ peaks were statistically significant (Table 1) .
Control BALB/c NK cells stained with YE1/48 mAb revealed a peak which was less intense (Fig. 1F) than that of nontransplanted B6 controls (Fig. 1E) . Donor (BALB/c) NK cells in the mixed chimeras displayed an Ly-49A peak whose intensity resembled that of non-transplanted BALB/c controls ( Fig. 1H and Table 2 ).
5E6 staining of NK cells in mixed chimeras
Ly-49C, which is recognized by the mAb 5E6, was originally described as a molecule expressed on H-2 b or H-2 dϫb NK cells which were able to reject H-2 d bone marrow grafts (34) . Several alleles of the Ly-49C gene have been cloned (17, 18) , and it has been shown that Ly-49C ϩ cells from BALB/c mice transmit inhibitory signals upon recognition of K b and H-2 d antigens, while 5E6 ϩ cells in B6 mice are only inhibited by K b (35) . Recently, it has been reported that the mAb 5E6 recognizes Ly-49C and Ly-49I in B6 mice (21) .
No differences in the percentage of 5E6 ϩ NK cells or in the staining intensity of 5E6 were detected among host (B6) NK cells in mixed chimeras compared to non-transplanted B6 control animals (Fig. 2 , left panels, and Table 1) . No difference was detected when the Ly-49C-specific mAb, 4LO3311, was used (data not shown).
BALB/c mice do not express Ly-49I, so 5E6 stains only Ly-49C in this strain (21) . In BALB/c → B6 mixed chimeras, donor (BALB/c) NK cells included a higher percentage of 5E6 ϩ cells that stained with lower intensity than 5E6 ϩ NK cells in control BALB/c mice (Fig. 2, and Table 2 ).
Ly-49G2 expression on NK cells
Ly-49G2 is recognized by the 4D11 mAb, and its inhibitory ligands are H-2D d and L d (20, 36) . The level of Ly-49G2 expression was slightly decreased on host (B6) NK cells in mixed chimeras compared to B6 controls (Fig. 3, top panel) . The proportion of NK cells expressing Ly-49G2 was similar in both groups (Table 1 ). In contrast, donor 4D11 ϩ NK cells were increased in percentage and stained with higher intensity compared to those in non-transplanted BALB/c controls (Fig. 3 , bottom panel and Table 2 ). In view of reports that the 4D11 mAb is cross-reactive with Ly-49A (15,37), we also tested for this cross-reactivity. Supernatants containing 4D11 were examined for their ability to block staining of fluorochrome-labeled A1 or YE1/48 (1:5 dilution) on EL-4 tumor cells, NK cells from B6 mice and on NK cells from BALB/c mice. A1 mAb was blocked by 4D11 only on EL-4 tumor cells, but not on NK cells from B6 mice (Fig. 4) . 4D11 did not block binding of YE1/48 mAb to any of the cells tested, including BALB/c NK cells, EL-4 or B6 NK cells (not shown). Therefore, the cross-reactivity of these antiLy-49 mAb depends on the specific cell type examined.
Changes of Ly-49 receptor expression over time The data described above were obtained from animals sacrificed 5 weeks post-BMT. We also examined the expression of Ly-49 receptors at later time points. Unexpectedly, the levels of receptor expression were different on NK cells from animals sacrificed 7 weeks post-transplant than at 5 weeks. There was no difference in 4D11 staining on host (B6) NK cells in mixed chimeras compared to non-transplanted B6 controls by 7 weeks post-BMT (not shown), in contrast to the results at 5 weeks (Fig. 3) . 5E6 staining on host (B6) NK cells showed a similar pattern of staining at 5 and 7 weeks (not shown). However, by 7 weeks, the proportion of 5E6 ϩ host (B6) NK cells was decreased in mixed chimeras compared to B6 controls [host (B6) NK cells in mixed chimeras: mean Ϯ SD ϭ 33.05 Ϯ 5.33%; non-BMT B6 controls: 46.66 Ϯ 6.33%, n ϭ 4 per group, P Ͻ 0.05]. The expression of some Ly-49 receptors also changed on donor NK cells over time. While at 5 weeks 5E6 stained an increased percentage of donor (BALB/c) NK cells with decreased intensity compared to BALB/c controls (Fig. 2) 
5E6 and 4D11 'DP' host and donor NK cells
Host (B6) NK cells from BALB/c → B6 chimeras showed differences in the pattern of dual staining with 5E6 and 4D11 mAb compared to non-transplanted B6 controls (Fig. 5 , left panels). Consistent with data in Fig. 3 , B6 NK cells in mixed chimeras showed a lower intensity of staining with 4D11 compared to the controls. However, while overall intensity of 5E6 staining on B6 NK cells was similar for chimeras and controls (Fig. 2) , differences could be detected when the 5E6 ϩ cells were resolved into 4D11 ϩ and 4D11 -populations (Fig. 5, left panels) . 5E6 ϩ 4D11 ϩ (DP) NK cells in non-transplanted B6 controls showed an overall unimodal pattern of staining. Host (B6) NK cells of mixed chimeras, however, included two distinct DP populations. One was a small 'bright' DP population that was similar to control DP cells in the intensity of 4D11 staining. The second was a larger 'intermediate' staining population (Fig. 5, lower left panel, arrows) , which showed a lower average level of staining of both 4D11 and 5E6 compared to DP cells in the B6 controls. The 5E6 ϩ 4D11 -cells in the two groups did not show any obvious differences in levels of 5E6 expression, but the host 5E6 -4D11 ϩ cells in mixed chimeras showed a lower level of 4D11 staining than those in B6 controls (Fig. 5, left panels) .
Among donor (BALB/c) NK cells in mixed chimeras, most DP cells expressed the 5E6 determinant at a lower intensity compared to those in non-transplanted BALB/c controls (Fig.  5 , right panels), consistent with results in Fig. 2 . The intensity of 4D11 staining was similar between DP donor (BALB/c) NK cells in chimeras and BALB/c controls. In addition, a small 'bright' DP NK cell population was evident in the chimeras (Fig. 5, bottom right panel, arrow) .
Alterations in the size of NK cell subsets which express more than one type of Ly-49 receptor might be a mechanism by which responsiveness to both donor and host MHC antigens could be achieved in mixed chimeras. To test this hypothesis, we compared the proportion of 5E6 ϩ and 4D11 ϩ cells that were DP versus single-positive in each group, and found a decrease in the proportion of host 5E6 ϩ cells that also expressed 4D11 in mixed chimeras compared to B6 controls [mean % (DP/total 5E6 ϩ ) Ϯ SD: host B6 NK cells in mixed chimeras: 34.64 Ϯ 3.13, n ϭ 3; B6 controls: 48.45 Ϯ 3.53, n ϭ 4, P Ͻ 0.005]. In contrast to host (B6) NK cells in the same animals, the donor (BALB/c) NK cells in mixed chimeras showed an increase in the proportion of 5E6 ϩ cells that also expressed 4D11, compared to BALB/c controls [mean % (DP/total 5E6 ϩ ) Ϯ SD: donor BALB/c in mixed chimeras: 37.04 Ϯ 4.50, n ϭ 4, BALB/c controls: 27.38 Ϯ 3.73, n ϭ 5, P Ͻ 0.02]. Thus, in mixed chimeras, the proportion of 5E6 ϩ cells expressing Ly-49G2 tended in the direction of being 'BALB/c -like' among B6 (host) NK cells and was somewhat ' B6-like' for the BALB/c (donor) NK cells.
5E6 versus YE1/48 staining on host and donor NK cells
Host (B6) NK cells stained with 5E6 and YE1/48 mAb showed an overall decrease in intensity of staining with YE1/48 in both DP (YE1/48 ϩ 5E6 ϩ ) and single-positive populations compared to B6 controls (data not shown), consistent with the data in Fig. 1 . In addition, the average intensity of 5E6 staining was lower among host DP cells of mixed chimeras than among DP cells of B6 controls (data not shown). However, the proportion of DP cells among 5E6 ϩ or YE1/48 ϩ cells was not significantly different between host (B6) NK cells in mixed chimeras and B6 controls (data not shown). Donor (BALB/c) NK cells that were DP for 5E6 and YE1/48 showed a lower average intensity of 5E6 staining compared with controls, but there was no apparent difference in YE1/48 staining compared to BALB/c controls (not shown).
Ly-49 receptor expression in syngeneic BMT recipients
To confirm that the changes in Ly-49 receptor expression observed in mixed allogeneic chimeras were in response to the allogeneic MHC and not due to the BMT procedure itself, we transplanted a group of B6 recipients with syngeneic B6 bone marrow. We did not observe any differences in the levels of Ly-49 receptor expression on NK cells between syngeneic B6→ B6 BMT recipients and non-transplanted B6 controls (data not shown). This demonstrates that the altered Ly-49 receptor expression observed is due to the presence of the allogeneic MHC in the BALB/c → B6 mixed chimeras.
Analysis of NK cell tolerance in vitro
Given the striking changes observed in Ly-49 receptor expression, we performed in vitro functional NK cell assays to test whether host and donor NK cells were tolerant to each other. In all assays, CD3 ϩ cells were depleted before culture and were not present among the IL-2 activated NK cells postculture (data not shown). Surprisingly, donor (BALB/c) NK cells from mixed chimeras efficiently lysed both host (B6) and β 2 m -/-targets, indicating that donor (BALB/c) NK cells developing in BALB/c → B6 mixed chimeras were not tolerant to host (B6) antigens (Fig. 6 ). These donor (BALB/c) NK cells lysed B6 targets more efficiently than did BALB/c NK cells from non-transplanted controls.
Host (B6) NK cells from mixed chimeras lysed BALB/c targets to a similar degree to that observed for NK cells from controls ( Fig. 7) , indicating a lack of tolerance to the donor. Despite their ability to lyse BALB/c targets, host B6 NK cells were hyporesponsive to β 2 m -/-targets (Fig. 7) . Although lysis of BALB/c targets by NK cells of non-transplanted B6 control mice was low, it was greater than that of B6 syngeneic targets (data not shown).
In the studies described above, in order to reproduce the in vivo mixed chimeric environment, purified host and donor NK cells from mixed chimeras were cultured with a 50:50 mixture of host and donor-type irradiated spleen cells or with irradiated, unseparated spleen cells harvested from mixed chimeric animals before purification of the NK cells (i.e. both host and donor-type cells were present in the feeder population). Thus, it remained possible that the presence of allogeneic feeders during culture in IL-2 affected the ability of NK cells from mixed chimeras to lyse particular targets. To address this possibility, we compared the specificity of killing by NK cells from naive B6 and naive BALB/c mice cultured in IL-2 plus syngeneic feeders alone, allogeneic feeders alone or a 1:1 mixture of syngeneic and allogeneic feeders. NK cells cultured with the different groups of feeders did not lyse self targets, and killed allogeneic targets and β 2 m -/-targets efficiently (data not shown). Thus, the presence of allogeneic feeders during culture did not alter the specificity of NK cell killing.
Discussion
Mixed chimerism induced with a non-myeloablative regimen leads to permanent acceptance of donor-specific tissues without requiring chronic immunosuppressive therapy (24, 25) . This powerful method of inducing T cell tolerance is dependent upon the engraftment and function of donor hematopoietic stem cells, which provide a life-long source of donor antigens that can induce deletion of donor-reactive cells in the thymus (38) . Since NK cells in mixed chimeras are of both donor and host origin, and NK cells have the capacity to destroy allogeneic hematopoietic cells (5,6), we reasoned that a state of NK cell tolerance of both donor and host might be necessary in order for chimerism to persist at constant levels throughout life, as has been observed (24, 25) . Alternatively, since NK cells do not have a strong ability to destroy the most primitive pluripotent hematopoietic stem cells (39) , but clearly have the capacity to destroy committed hematopoietic progenitor cells (5, 40) , a state of mutual non-tolerance of donor and host NK cells might also lead to an overall constant level of chimerism, provided the rate of hematopoiesis is sufficiently rapid to replenish donor and host progenitors as they are destroyed by host and donor NK cells respectively. The present studies were therefore carried out to determine whether or not donor and host NK cells were mutually tolerant in mixed allogeneic chimeras produced across a full MHC barrier. The results of our studies are consistent with a model in which the level of Ly-49 molecule expression on NK cells is determined by the requirement to be sensitive to perturbations in the expression of MHC molecules encountered in the environment of the NK cell. Thus, a dominant down-regulation of Ly-49 molecules is observed in response to the presence of MHC molecules to which the Ly-49 receptors bind, regardless of whether the MHC molecule is expressed on a 'self' or a 'non-self' cell in the mixed chimeric environment. The observation that B6 NK cells down-regulate Ly-49G2 and Ly-49A (both of which effectively bind to D d ) when H-2 d cells are present in BALB/c → B6 chimeras is evidence for this. Likewise, BALB/c NK cells in mixed chimeras down-regulate Ly49C, which appears to bind to H-2 b molecules more effectively than H-2 d (21, 35) . The result is that BALB/c and B6 NK cells tend to resemble one another in the expression of Ly-49 molecules when they develop in the mixed chimeric environment (summarized in Table 3 ). The expected functional consequence of these alterations would be that both types of NK cells could be activated in the presence of perturbations in the expression of MHC molecules on either donor or host cells in the mixed chimera. For example, if class I MHC expression was down-regulated due to infection with a virus (41), both donor and host NK cells could respond to this perturbation and destroy both donor and host target cells showing this alteration.
In contrast to this observed mechanism for making NK cells functional in response to perturbations in MHC molecules expressed by donor or host cells, our studies do not provide strong evidence for mechanisms by which NK cells can be rendered 'tolerant' of MHC antigens. In contrast, functional studies of NK cell tolerance using F 1 (AϫB) → parent (A or B) bone marrow chimeras (9) and β 2 m ϩ/ϩ → β 2 m -/-fetal liver irradiation chimeras (8) have suggested that the recognition specificity of NK cells is dependent, at least in part, on the host environment and on the MHC expressed on hematopoietic cells; i.e. that tolerance develops. Furthermore, NK cells developing in mice with mosaic expression of a MHC transgene (Tg) are unable to lyse either MHC-Tg ϩ or MHCTg -targets in vitro and do not reject bone marrow from MHCTg ϩ or MHC-Tg -donors (42) . However, the mixed, fully allogeneic MHC-disparate chimera model used in the current study places much greater constraints on MHC recognition by NK cells than do any of these other models. As a consequence of the dominant down-regulation of Ly-49 receptors imposed by the presence of two fully disparate MHC haplotypes expressed on different cells, it may be impossible for the NK cell repertoire to be simultaneously tolerant to both types of MHC antigens. Since the repertoire of known Ly-49 molecules is quite small, and these tend to cross-react between MHC alleles (15) , this outcome of lack of tolerance to allogeneic MHC is perhaps not surprising. This fully mismatched setting is highly relevant to the clinical application of mixed chimerism for the induction of tolerance to fully mismatched cadaveric organ allografts.
Our results do provide some evidence for Ly-49 up-regulation in response to the presence of allogeneic MHC in mixed chimeras. In particular, the proportion of Ly-49G2 ϩ cells and intensity of Ly-49G2 staining on donor (BALB/c) NK cells in mixed chimeras was increased compared to that on BALB/c controls, deviations that make them somewhat 'B6-like'. The increased intensity of Ly-49G2 on donor (BALB/c) NK cells in mixed chimeras and on normal B6 NK cells raises the possibility that a low-affinity interaction between Ly-49G2 and H-2 b antigens may lead to NK cell inhibition by H-2 b antigens if Ly-49G2 is expressed at sufficiently high levels. Although an inhibitory effect of binding of H-2 b molecules to Ly-49G2 has not been detected (20) Although a lack of tolerance of BALB/c donor NK cells to host antigens was a universal finding in our studies, all of the chimeras examined in functional assays contained high proportions of BALB/c hematopoietic cells (~80%). It is possible that, if higher levels of host-type hematopoietic cells were present, a greater degree of tolerance to the host would be observed. Our previous studies showed that the magnitude of the effect of D d on Ly49A expression was dependent on the level of D d expression and was greater if D d was expressed on hematopoietic cells than if it was expressed only on the non-hematopoietic environment (23) . Similar results have been obtained in functional assays in the β 2 m ϩ/ϩ → β 2 m -/-combination (8) . Consistent with the possibility that NK cells can be tolerized to alloantigens in mixed chimeras, we have observed tolerance of B6 NK cells for BALB/c antigens in one experiment (data not shown). However, the two experiments in which we used purified NK cells gave results similar to those shown in Fig. 7 , i.e. generalized hyporesponsiveness for B6 NK cells in mixed chimeras, with no evidence for tolerance to BALB/c alloantigens. The hyporesponsiveness of B6 NK cells developing in mixed chimeras towards β 2 m -/-targets is puzzling, given the observed down-regulation of Ly-49 receptors. Perhaps, in order to maintain self-tolerance, the down-regulation of Ly-49A and Ly-49G2 was compensated for by the up-regulation of a yet-to-be-defined H-2 b -recognizing receptor, which in turn may also be inhibited by the low levels of class I MHC expressed by β 2 m -/-mice. This possibility is consistent with the finding that human NK cells use several other classes of inhibitory receptors, i.e. Ig superfamily members (45) and CD94/NKG2 (46) . In mice, these other inhibitory receptors have only recently been described (47) (48) (49) . Furthermore, additional members of the Ly-49 family may exist that have not yet been defined. The high levels of expression of known Ly-49 receptors on NK cells from β 2 m -/-mice (37) are consistent with inhibitory receptor up-regulation as a mechanism of NK cell self-tolerance.
The lack of mutual tolerance of NK cells in mixed chimeras raises the question as to why chimerism remains stable over time in mixed chimeras prepared in this strain combination. As is discussed above, a state of mutual non-tolerance of donor and host NK cells might lead to an overall constant level of chimerism if the rate of hematopoiesis was sufficiently rapid to replenish donor and host progenitors as they were destroyed by host and donor NK cells respectively. Furthermore, there may be some degree of strain dependence in the ability to achieve stable mixed chimerism. We have observed a tendency toward increasing levels of donor hematopoiesis over time in the BALB/c → B6 strain combination used here and in the opposite direction (i.e. decreasing donor hematopoiesis over time) in the B6 → BALB/c strain combination (data not shown). These observations are consistent with the studies of other groups showing greater NK cell-mediated alloresistance to Hh-1 bϩ marrow than Hh-1 dϩ marrow by F 1 (bϫd) recipients (50). Chadwick and Miller have also observed that (BALB/cϫB6) NK cells lysed B6 targets more effectively than BALB/c targets (10) . This imbalance may reflect a greater tendency of Ly-49 molecules to cross-react on H-2 d than on H-2 b , in which case the likelihood of Ly-49 molecules expressed on B6 NK cells also being able to recognize H-2 d molecules would be greater than the likelihood of the converse.
Changes in Ly-49 receptor expression over time were observed in mixed chimeras, demonstrating that evolution of the NK cell repertoire occurs over time. This may relate to changes in chimerism that occur over time, as is discussed above. We have observed a linear correlation between the percentage of donor (H- (51) . NK cell activity studies suggest that the life span of an NK cell is relatively short in the spleen [with a half-life of 1 day (52) to a total life span of 2 weeks (53)]. Thus, our observation of changes in Ly-49 receptor expression between five and 7 weeks post-BMT does not distinguish between adaptations of individual mature NK cells over time versus the changes in the maturing NK cell repertoire over time.
In conclusion, expression of MHC ligands in the environment has a dominant down-regulating effect on the expression of Ly-49 molecules that recognize donor and host MHC. We speculate that, because the repertoire of Ly-49 molecules is rather limited, the requirement for sensitivity to perturbations in both H-2 b and H-2 d antigen expression results in an inability of NK cells in mixed chimeras to adequately up-regulate Ly-49 molecules that recognize non-self MHC and hence in a lack of functional tolerance. The fact that tolerance to 'self' is preserved suggests that MHC molecules expressed by the NK cell itself may more readily induce up-regulation of inhibitory Ly-49 molecules that will make it self-tolerant. Further studies are needed to address these hypotheses.
